Mayumi Kitagawa

2.5k total citations
64 papers, 1.9k citations indexed

About

Mayumi Kitagawa is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Mayumi Kitagawa has authored 64 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 20 papers in Neurology and 16 papers in Oncology. Recurrent topics in Mayumi Kitagawa's work include Parkinson's Disease Mechanisms and Treatments (18 papers), Neurological disorders and treatments (18 papers) and Cancer-related Molecular Pathways (13 papers). Mayumi Kitagawa is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (18 papers), Neurological disorders and treatments (18 papers) and Cancer-related Molecular Pathways (13 papers). Mayumi Kitagawa collaborates with scholars based in Japan, Singapore and United States. Mayumi Kitagawa's co-authors include Kunio Tashiro, Sang Hyun Lee, Seiji Kikuchi, Frank McCormick, Junichi Murata, Hisatoshi Saito, Sang Hyun Lee, Haruo Uesugi, Yutaka Sawamura and Junko Fukushima and has published in prestigious journals such as Nature Communications, Blood and Molecular Cell.

In The Last Decade

Mayumi Kitagawa

63 papers receiving 1.9k citations

Peers

Countries citing papers authored by Mayumi Kitagawa

Since Specialization

Citations

This map shows the geographic impact of Mayumi Kitagawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayumi Kitagawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayumi Kitagawa more than expected).

Fields of papers citing papers by Mayumi Kitagawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayumi Kitagawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayumi Kitagawa. The network helps show where Mayumi Kitagawa may publish in the future.

Co-authorship network of co-authors of Mayumi Kitagawa

This figure shows the co-authorship network connecting the top 25 collaborators of Mayumi Kitagawa. A scholar is included among the top collaborators of Mayumi Kitagawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayumi Kitagawa. Mayumi Kitagawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Leveraging virtual reality for advanced scrub nurse education: A non-randomized comparative study of training effectiveness 2024 ·Clinical Simulation in Nursing ·(unknown), Mayumi Kitagawa, (unknown), (unknown), (unknown), (unknown)	0
2	A Ras-LSD1 axis activates PI3K signaling through PIK3IP1 suppression 2020 ·Oncogenesis ·Kyunghee Lee, Mayumi Kitagawa, (unknown), David M. Virshup, Sang‐Hyun Lee	8
3	Neuroimaging and neurophysiological evaluation of severity of Parkinson’s disease 2020 ·Journal of Clinical Neuroscience ·(unknown), Rei Enatsu, Mayumi Kitagawa, Masayasu Arihara, (unknown), (unknown), Hime Suzuki, (unknown), Takeshi Mikami, Nobuhiro Mikuni	8
4	Choreo-ballistic movement after thalamotomy in a patient with Lewy body dementia 2019 ·Journal of Clinical Neuroscience ·(unknown), Rei Enatsu, Mayumi Kitagawa, Takashi Morishita, Yuto Suzuki, Takeshi Mikami, Nobuhiro Mikuni	1
5	Prodrugs of the cancer cell selective anti-cancer agent (Z)-2-(1H-indol-3-yl)-3-(isoquinolin-5-yl)acrylonitrile (A131) are orally efficacious in a mouse model of resistant colon cancer 2018 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Mayumi Kitagawa, Pei‐Ju Liao, Kyung Hee Lee, Jasmine C. Wong, Sang Hyun Lee, Brian Dymock	4
6	Discovery of the cancer cell selective dual acting anti-cancer agent (Z)-2-(1H-indol-3-yl)-3-(isoquinolin-5-yl)acrylonitrile (A131) 2018 ·European Journal of Medicinal Chemistry ·(unknown), Mayumi Kitagawa, Pei‐Ju Liao, Kyung Hee Lee, Jasmine C. Wong, Sang Hyun Lee, Brian Dymock	13
7	CoA synthase regulates mitotic fidelity via CBP-mediated acetylation 2018 ·Nature Communications ·Chao‐Chieh Lin, Mayumi Kitagawa, Xiaohu Tang, (unknown), Jianli Wu, (unknown), (unknown), Xiaojing Liu, J. Will Thompson, Bernard Mathey-Prévôt, Tso‐Pang Yao, Sang Hyun Lee, Jen‐Tsan Chi	35
8	Loss of the Greatwall Kinase Weakens the Spindle Assembly Checkpoint 2016 ·PLoS Genetics ·M. Kasim Diril, Xavier Bisteau, Mayumi Kitagawa, Matias J. Caldez, Sheena Wee, Jayantha Gunaratne, Sang Hyun Lee, Philipp Kaldis	33
9	Opposing Activities of Aurora B Kinase and B56-PP2A Phosphatase on MKlp2 Determine Abscission Timing 2016 ·Current Biology ·(unknown), Mayumi Kitagawa, Pei‐Ju Liao, (unknown), Sang Hyun Lee	24
10	Discovery of DS-5272 as a promising candidate: A potent and orally active p53–MDM2 interaction inhibitor 2015 ·Bioorganic & Medicinal Chemistry ·Masaki Miyazaki, Kouichi Uoto, (unknown), Hiroyuki Naito, Keisuke Yoshida, (unknown), Haruko C. Kawato, (unknown), (unknown), Mayumi Kitagawa, Takahiko Seki, (unknown), Masashi Aonuma, Tsunehiko Soga	31
11	Cdk1 Coordinates Timely Activation of MKlp2 Kinesin with Relocation of the Chromosome Passenger Complex for Cytokinesis 2014 ·Cell Reports ·Mayumi Kitagawa, (unknown), Umar F. Shahul Hameed, Hidemasa Goto, Masaki Inagaki, Sang Hyun Lee	57
12	Synthesis and evaluation of novel orally active p53–MDM2 interaction inhibitors 2013 ·Bioorganic & Medicinal Chemistry ·Masaki Miyazaki, Hiroyuki Naito, (unknown), Keisuke Yoshida, Haruko C. Kawato, (unknown), (unknown), (unknown), (unknown), Mayumi Kitagawa, Takahiko Seki, (unknown), Yoshinobu Shiose, Masashi Aonuma, Tsunehiko Soga	26
13	Expanding the clinical phenotype of SNCA duplication carriers 2009 ·Movement Disorders ·Kenya Nishioka, Owen A. Ross, Kenji Ishii, Jennifer M. Kachergus, Kiichi Ishiwata, Mayumi Kitagawa, Satoshi Kono, Tomokazu Obi, Koichi Mizoguchi, Yuichi Inoue, Hisamasa Imai, Masashi Takanashi, Yoshikuni Mizuno, Matthew J. Farrer, Nobutaka Hattori	97
14	Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of Cyclin D1-CDK4: Synthesis, biological evaluation and structure–activity relationships. Part 2 2009 ·Bioorganic & Medicinal Chemistry ·Takao Horiuchi, (unknown), Mayumi Kitagawa, Kouichi Akahane, Kouichi Uoto	62
15	Skp2 Suppresses p53-Dependent Apoptosis by Inhibiting p300 2008 ·Molecular Cell ·Mayumi Kitagawa, Sang Hyun Lee, Frank McCormick	98
16	Pure Topographical Disorientation Following a Right Forceps Major of the Splenium Lesion: A Case Study 2007 ·Neurocase ·(unknown), Mayumi Kitagawa, Mika Otsuki, Seiji Kikuchi, Kunio Tashiro, Bruno Dubois	22
17	Current Situation and Future of Gastric Cancer Screening Examinations : From the Viewpoint of Gastric X-ray Screening 2005 ·Japanese Journal of Radiological Technology ·Mayumi Kitagawa	1
18	DJ‐927, a novel oral taxane, overcomes P‐glycoprotein‐mediated multidrug resistance in vitro and in vivo 2003 ·Cancer Science ·(unknown), Takeshi Jimbo, Mayumi Kitagawa, Tsunehiko Soga, Akiko Tohgo	67
19	Electrical stimulation of the posterior subthalamic area for the treatment of intractable proximal tremor 2003 ·Journal of neurosurgery ·Junichi Murata, Mayumi Kitagawa, Haruo Uesugi, Hisatoshi Saito, Yoshinobu Iwasaki, Seiji Kikuchi, Kunio Tashiro, Yutaka Sawamura	132
20	Direct association of LIS1, the lissencephaly gene product, with a mammalian homologue of a fungal nuclear distribution protein, rNUDE 2000 ·FEBS Letters ·Mayumi Kitagawa, (unknown), Junken Aoki, Hiroyuki Koizumi, Hiroyuki Arai, Keizo Inoue	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact